Tuffery-Giraud et al. described data from the French UMD–DMD database including DMD molecular defects and clinical characteristics of 2405 patients with dystrophinopathy at a nationwide level: only one asymptomatic male patient was identified (12). The gene discussed is DMD; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.